PELTHOS THERAPEUTICS INC. (PTHS) scores 43 out of 100 on boothcheck's 11-model valuation framework. Verdict: Poor The estimated fair value is 1.64, representing a 93% premium to fair value. Quantitative score: 44/100. Qualitative score: 70/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.